Recruiting
Focal segmental glomerulosclerosis
RecruitingInvestigational
A study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
Investigational
- Disease:Focal segmental glomerulosclerosis
- Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
Countries:
Norway
Norway- Participants:0–17 years · 18–64 years · 65+ years
- Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
